These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 20647592)

  • 1. Increased abundance of opioid receptor heteromers after chronic morphine administration.
    Gupta A; Mulder J; Gomes I; Rozenfeld R; Bushlin I; Ong E; Lim M; Maillet E; Junek M; Cahill CM; Harkany T; Devi LA
    Sci Signal; 2010 Jul; 3(131):ra54. PubMed ID: 20647592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors.
    Yadlapalli JSK; Ford BM; Ketkar A; Wan A; Penthala NR; Eoff RL; Prather PL; Dobretsov M; Crooks PA
    Pharmacol Res; 2016 Nov; 113(Pt A):335-347. PubMed ID: 27637375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional relevance of μ-δ opioid receptor heteromerization: a role in novel signaling and implications for the treatment of addiction disorders: from a symposium on new concepts in mu-opioid pharmacology.
    Stockton SD; Devi LA
    Drug Alcohol Depend; 2012 Mar; 121(3):167-72. PubMed ID: 22115888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. μ-δ opioid receptor heteromer-specific signaling in the striatum and hippocampus.
    Kabli N; Fan T; O'Dowd BF; George SR
    Biochem Biophys Res Commun; 2014 Jul; 450(1):906-11. PubMed ID: 24976397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine-dependent and abstinent mice are characterized by a broader distribution of the neurons co-expressing mu and delta opioid receptors.
    Pierre F; Ugur M; Faivre F; Doridot S; Veinante P; Massotte D
    Neuropharmacology; 2019 Jul; 152():30-41. PubMed ID: 30858104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonists at the δ-opioid receptor modify the binding of µ-receptor agonists to the µ-δ receptor hetero-oligomer.
    Kabli N; Martin N; Fan T; Nguyen T; Hasbi A; Balboni G; O'Dowd BF; George SR
    Br J Pharmacol; 2010 Nov; 161(5):1122-36. PubMed ID: 20977461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-analgesic effect of the mu/delta opioid receptor heteromer revealed by ligand-biased antagonism.
    Milan-Lobo L; Enquist J; van Rijn RM; Whistler JL
    PLoS One; 2013; 8(3):e58362. PubMed ID: 23554887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a μ-δ opioid receptor heteromer-biased agonist with antinociceptive activity.
    Gomes I; Fujita W; Gupta A; Saldanha SA; Negri A; Pinello CE; Eberhart C; Roberts E; Filizola M; Hodder P; Devi LA
    Proc Natl Acad Sci U S A; 2013 Jul; 110(29):12072-7. PubMed ID: 23818586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of opioid agonists on G protein expression in CHO cells expressing cloned human opioid receptors.
    Xu H; Wang X; Partilla JS; Bishop-Mathis K; Benaderet TS; Dersch CM; Simpson DS; Prisinzano TE; Rothman RB
    Brain Res Bull; 2008 Sep; 77(1):49-54. PubMed ID: 18639745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.
    Noble F; Cox BM
    Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mu and Delta Opioid Receptors Are Coexpressed and Functionally Interact in the Enteric Nervous System of the Mouse Colon.
    DiCello JJ; Carbone SE; Saito A; Rajasekhar P; Ceredig RA; Pham V; Valant C; Christopoulos A; Veldhuis NA; Canals M; Massotte D; Poole DP
    Cell Mol Gastroenterol Hepatol; 2020; 9(3):465-483. PubMed ID: 31759144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for the distal carboxyl tails in generating the novel pharmacology and G protein activation profile of mu and delta opioid receptor hetero-oligomers.
    Fan T; Varghese G; Nguyen T; Tse R; O'Dowd BF; George SR
    J Biol Chem; 2005 Nov; 280(46):38478-88. PubMed ID: 16159882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofilament proteins and cAMP pathway in brains of mu-, delta- or kappa-opioid receptor gene knock-out mice: effects of chronic morphine administration.
    García-Sevilla JA; Ferrer-Alcón M; Martín M; Kieffer BL; Maldonado R
    Neuropharmacology; 2004 Mar; 46(4):519-30. PubMed ID: 14975676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences among mouse strains in the regulation by mu, delta 1 and delta 2 opioid receptors of striatal adenylyl cyclases activated by dopamine D1 or adenosine A2a receptors.
    Noble F; Cox BM
    Brain Res; 1996 Apr; 716(1-2):107-17. PubMed ID: 8738226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain regional Fos expression elicited by the activation of mu- but not delta-opioid receptors of the ventral tegmental area: evidence for an implication of the ventral thalamus in opiate reward.
    David V; Matifas A; Gavello-Baudy S; Decorte L; Kieffer BL; Cazala P
    Neuropsychopharmacology; 2008 Jun; 33(7):1746-59. PubMed ID: 17895918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a mu-delta opioid receptor complex in CHO cells co-expressing mu and delta opioid peptide receptors.
    Rutherford JM; Wang J; Xu H; Dersch CM; Partilla JS; Rice KC; Rothman RB
    Peptides; 2008 Aug; 29(8):1424-31. PubMed ID: 18472184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception.
    Cahill CM; Morinville A; Lee MC; Vincent JP; Collier B; Beaudet A
    J Neurosci; 2001 Oct; 21(19):7598-607. PubMed ID: 11567050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of an Opioid Receptor Chaperone Protein, RTP4, by Morphine.
    Fujita W; Yokote M; Gomes I; Gupta A; Ueda H; Devi LA
    Mol Pharmacol; 2019 Jan; 95(1):11-19. PubMed ID: 30348895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential modulation of mu- and delta-opioid receptor agonists by endogenous RGS4 protein in SH-SY5Y cells.
    Wang Q; Liu-Chen LY; Traynor JR
    J Biol Chem; 2009 Jul; 284(27):18357-67. PubMed ID: 19416973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heteromers of μ-δ opioid receptors: new pharmacology and novel therapeutic possibilities.
    Fujita W; Gomes I; Devi LA
    Br J Pharmacol; 2015 Jan; 172(2):375-87. PubMed ID: 24571499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.